Want to join the conversation?
The pharmacy benefit manager $ESRX reported 3Q15 net income of $661.7MM or $0.97 per diluted share. $ESRX said it had revenue of $25.22Bil compared to $25.77Bil in the prior year period. Adjusted claims during the quarter were 328.3MM and adjusted EBITDA was $1,808.3MM, up 4% YoverY.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.
$SPY can the rally continue? La Pen almost assured to lose makes me cautious about the results, not a place to panic. If 2400 is reached I'm selling my puts and going for broke. Happy hunting.